Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy

This publication has 120 references indexed in Scilit:

• Antibodies Specific to the Plasma Membrane of Rat Lung Microvascular Endothelium
  Experimental Cell Research, 1997
• Pulmonary Embolism. II. Diagnosis and Treatment
  Seminars in Thrombosis and Hemostasis, 1996
• Immunoselective Targeting of an Anti-Thrombin Agent to the Surface of Cytokine-Activated Vascular Endothelial Cells
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Targeted delivery of immunomicrospheresin vivo
  Drug Delivery, 1995
• Expanding the paradigm of the renin-angiotensin system and angiotensin-converting enzyme inhibitors
  American Heart Journal, 1994
• Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.
  Hypertension, 1990
• Inhibition of oxygen toxicity by targeting Superoxide dismutase to endothelial cell surface
  FEBS Letters, 1990
• Production of monoclonal antibodies to rat lung angiotensin-converting enzyme
  Clinical Immunology and Immunopathology, 1984
• Lung injury mediated by antibodies to endothelium. I. In the rabbit a repeated interaction of heterologous anti-angiotensin-converting enzyme antibodies with alveolar endothelium results in resistance to immune injury through antigenic modulation.
  The Journal of Experimental Medicine, 1983
• In vitro and in vivo effects of antibody to rat angiotensin converting enzyme
  Clinical Immunology and Immunopathology, 1980